Ascentage Pharma Group Internat (AAPG) — Stock Score Summary

Ascentage Pharma Group Internat (AAPG) has a MoatMap StockRank of 1/100 based on Quality (16/100), Value (36/100), and Momentum (18/100) factor scores. The current signal is STRONG SELL. Ascentage Pharma is a clinical-stage biotech that lacks the established commercial cash flows or CDMO pricing power we seek.

Ascentage Pharma Group International is a China-based, clinical-stage biotechnology company developing novel therapies for cancers, hepatitis B, and age-related diseases. The company's proprietary drug discovery platform focuses on targeting protein-protein interactions to restore apoptosis, or programmed cell death, in cancer cells. Ascentage holds a leading position in the Chinese oncology space, supported by a robust pipeline of first-in-class and best-in-class small-molecule candidates.

Key Financial Metrics

Price$17.07
Market Cap$1.9B
P/E (Forward)-15.30
Price/Book8.65
Return on Equity-154.6%
Return on Invested Capital-50.9%
Debt/Equity148.38
Gross Margin91.5%
Operating Margin-193.3%
Revenue Growth117.0%
Free Cash Flow$-943M

Ascentage Pharma Group Internat operates in the Biotechnology industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Ascentage Pharma Group Internat’s (AAPG) StockRank?
MoatMap’s StockRank for Ascentage Pharma Group Internat (AAPG) is 1/100, with a Strong Sell signal. It is a composite of Quality (16), Value (36), and Momentum (18) factor ranks across MoatMap’s 19,000+ stock universe.
Does Ascentage Pharma Group Internat have an economic moat?
Ascentage Pharma Group Internat (AAPG) has a Quality factor score of 16/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Ascentage Pharma Group Internat a buy, hold, or sell?
MoatMap’s current signal for Ascentage Pharma Group Internat (AAPG) is Strong Sell, based on a StockRank of 1/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Ascentage Pharma Group Internat in?
Ascentage Pharma Group Internat (AAPG) operates in the Healthcare sector, specifically the Biotechnology industry (China).
Browse all ranked stocksAAPG deep dive reportAI ChampionsHow we score stocksSense-check another stock